GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA's list of AI authorizations for 4th Year with 100
Milestone advances GE HealthCare's goal of attaining more than 200 authorizations by 2028
CHICAGO, July 23, 2025--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date in the U.S.
This milestone reflects GE HealthCare's continued research and development (R&D) investment and focus on developing AI solutions to advance precision care by enhancing medical devices across the care journey. Smart devices, software, and cloud-based solutions, which are central to GE HealthCare's precision care strategy, help enhance outcomes for patients, improve the daily work of care teams, and boost healthcare professional efficiency. These AI-enabled devices help solve customer challenges and are in high demand, which contributes to orders, revenue, and growth for the company. The momentum demonstrates GE HealthCare's progress toward achieving its goal of securing more than 200 authorizations.
"Our sustained leadership in AI-enabled medical devices reflects our commitment to research and development, which is powering the creation of next-generation solutions. These solutions are designed to address the toughest challenges our customers are facing including care team shortages and burnout, rising costs, and inefficient workflows," said Dr. Taha Kass-Hout, GE HealthCare's Global Chief Science and Technology Officer. "As we continue to drive the industry forward, we remain committed to doing so in a responsible way, building in our Responsible AI principles at every stage of our product development which include a focus on safety, validity, transparency, explainability, and fairness."
The FDA's webpage, Artificial Intelligence-Enabled Medical Devices, provides a list of device authorizations, granted through 510(k) clearances, De Novo requests, or by premarket approval (PMA). GE HealthCare's 100 authorizations to date demonstrate innovation across imaging modalities and care pathways including oncology, cardiology, and neurology, helping to ease the burden of care and improve workflows for healthcare systems. Examples of GE HealthCare's AI solutions that are helping solve customer challenges and driving growth include:
AI-based Auto Positioning uses deep learning to automatically detect anatomical landmarks, which are used to determine the patient's orientation inside computed tomography (CT) and positron emission tomography (PET)/CT devices, including Revolution Apex platform and Omni Legend. The solution helps minimize the action required by technologists into a single click operation, enabling faster patient positioning compared to traditional manual positioning operations.1
AIR™ Recon DL is a pioneering deep learning algorithm for image reconstruction that enables radiologists to achieve pin-sharp images quicker. By combining magnetic resonance imaging (MRI) with deep learning, AIR™ Recon DL reduces artifacts, enhances image clarity, and shortens scan times by up to 50%.2 It has been estimated that more than 50 million patients have been scanned since its launch in 2020.3
The LOGIQ™ Series ultrasound portfolio of systems empowers clinicians to scan, diagnose, and treat a wide range of patients and conditions. With AI-powered automation, real-time workflow enhancements, and exceptional image quality, the LOGIQ Series is designed to facilitate faster, more efficient scanning and support diagnostic precision. Intelligent anatomy recognition enables dynamic image optimization as well as repeatable and reproducible automated measurements and results – providing elevated accuracy and greater diagnostic confidence.
Precision DL is deep learning-based image processing, available on the Omni Legend PET/CT system, that enhances image quality in PET/CT scans, providing clinicians with a powerful solution to aid in precise diagnoses, treatment planning, and monitoring with the image quality performance benefits typically associated with hardware-based Time-of-Flight (ToF) reconstruction, without compromising sensitivity, including improved contrast-to-noise ratio, contrast recovery4, and quantitative accuracy.5
Venue Family point-of-care ultrasound systems with AI-powered Caption Guidance™ software provides real-time, step-by-step guidance to help even new ultrasound users capture cardiac views and diagnostic-quality images successfully.
"We're accelerating the pace of innovation to meet the urgency of today's healthcare challenges. Reaching this milestone is also an important step along our journey of evolving from an imaging company to a healthcare solutions provider, enabling us to deliver holistic and integrated solutions that meet our customers' needs today and will help enable them to stay ahead in a rapidly evolving healthcare environment," said Kass-Hout.
GE HealthCare is pushing forward the boundaries of innovation by fostering new ways to use AI, cloud, and software to move the future of healthcare forward in a responsible way in devices, across the care journey, and at the hospital system level. These projects and innovations run the gamut from early R&D to commercially available solutions, often the result of working closely with leading medical institutions, universities, and technology companies to bring in the best thinking from industry, technology, and academia. Regardless of a project's maturity, GE HealthCare combines deep healthcare expertise, a commitment to responsible innovation, and pioneering spirit to help customers address pressing global challenges from aging populations, chronic disease management, remote care, and more.
For more information about GE Healthcare's AI-enabled medical device and enterprise software solutions, visit www.GEHealthCare.com.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.
GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™.
Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.
1 "AI-based Auto Positioning," February 2021, https://www.gehealthcare.com/-/jssmedia/gehc/us/images/products/revolution-ascend/files/ai-auto-positioning-white-paper.pdf?srsltid=AfmBOooIyJqujqRZlX8hYx20aPDSwn7oGMbtiGzvym3nGEMd_TqqtpFy.
2 AIR™ Recon DL, https://www.gehealthcare.ca/en-ca/products/magnetic-resonance-imaging/air-recon-dl.
3 Calculated using IB data with an estimation of 20 scans per day, 5.5 days per week, from 4 weeks after delivery to April 2025.
4 Precision DL with Omni Legend 32cm data improves Contrast Recovery (CR) by 11% on average and Contrast-to-Noise Ratio (CNR) by average of 23% as compared to non-ToF reconstruction. CR and CNR demonstrated using clinical data with inserted lesions of known size, location, and contrast. Using data from Omni Legend 32 cm, CR and CNR were measured using High Precision DL and QCHD.
5 Precision DL with Omni Legend 32cm improves feature quantitation accuracy by 14% as compared to Discovery MI with ToF reconstruction, at comparable noise level. Quantitation accuracy demonstrated using clinical data with inserted lesions of known size, location, and contrast (ground truth). Feature SUVmean from Omni Legend 32 cm with High Precision DL compared to SUVmean from Discovery MI 25 cm with QCFX.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250723673565/en/
Contacts
GE HealthCare Media Contact Sofia Mata-LeclercHead of Communications, Science and Technologysofia.mata-leclerc@gehealthcare.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
31 minutes ago
- CNBC
More stock market records, more trade deals, more trade talks — plus, lots of earnings
The S & P 500 rose every day this past week as trade deals, both in the works and announced, lent support to the market. The index heads into the final stretch of a strong July at record highs. For the week, the S & P 500 gained nearly 1.5%. The Nasdaq did not go wire to wire in the green this week, but it did rise 1%, closing at another record high. Ahead of the last trading day of the month on Thursday, the S & P 500 was up almost 3% for July, while the Nasdaq jumped 3.6%. The best session of the week came on Wednesday after President Donald Trump announced the night before what he called a "massive" trade agreement with Japan ahead of the Aug. 1 deadline. The deal settled on a 15% tariff on goods entering the United States from Japan, including automobiles. In exchange, Japan will invest $550 billion in America and open its market to more imports from the U.S. The trade focus now shifts to China and the European Union. Next week, Treasury Secretary Scott Bessent travels to Stockholm for talks with Chinese officials about extending the negotiating window for a trade deal. Regarding the EU, Trump said Friday he sees only a "50-50 chance" of a deal with the trading bloc. The president plans to meet with EU officials in Scotland on Sunday. .SPX .IXIC 5D mountain S & P 500 and Nasdaq 5-day performance The other big news of this past week was Trump's trip to the Federal Reserve on Thursday. He toured the central bank renovation site with Fed Chairman Jerome Powell. They spoke with reporters and had an uncomfortable moment over renovation costs. Trump signaled that he's no longer considering firing Powell. The president told reporters Friday that Powell and he had a "good meeting" about interest rates, and he believes the Fed will start cutting them. Powell has kept rates steady since December 2024, saying central bankers need more time to see how finalized tariffs will impact inflation. On the economy, the June existing home sales report was released on Wednesday, followed by June new home sales on Thursday. While sales of both were slower than expected, the reports diverged when it came to prices. The median price of a previously owned home sold in June was $435,300, up year over year and the 24th consecutive month of annual increases, according to the National Association of Realtors. However, government data showed the median sales price of new homes sold last month was $401,800 — below May and below year-ago levels. Watching housing price trends is important because it can give us signals on where shelter costs might be headed, which have been a key factor keeping overall inflation elevated. Second quarter earnings season has kicked into full gear, with results thus far coming in better than expected. According to FactSet, a third of the S & P 500 companies have already reported, with 80% of those delivering upside surprises to both sales and earnings expectations. Within the Club portfolio, we heard from Danaher, GE Vernova, Capital One, Honeywell, and Dover. Talk about a blowout. GE Vernova came into the quarterly print near all-time highs, setting a high bar of expectations, which it easily hopped over. The stock was rewarded with record highs and was our top performer of the week, with 12% gains. Shares have nearly doubled in 2025 versus the S & P 500's 8.6% advance this year. GE Vernova on Wednesday reported strong order growth and robust EBITDA margin expansion. EBITDA stands for earnings before interest, taxes, depreciation and amortization. Strong backlog growth also gives us confidence that end market demand remains healthy. "This era of accelerated electrification is driving unprecedented investments in reliable power, grid infrastructure, and decarbonization solutions," CEO Scott Strazik said on the post-earnings call. Danaher on Tuesday delivered a strong set of results, albeit against relatively low expectations. The company did outpace expectations on the top and bottom lines, thanks to strength in all key operating segments. While Chinese sales in biotechnology and life sciences grew, the positive numbers were overshadowed by sustained weakness in diagnostics due to the countries volume-based procurement program. The quarter was enough to spark a relief rally and keep us in the name. Danaher was our second-best performer this week, rising 8%. Despite a good week, the stock was still down 10.5% year to date. Capital One delivered a noisy quarter on Tuesday due to the Discover integration. While shares were among our losers this week, down 2.5%, they have been on a roll, up more than 19% year to date. We saw enough the quarter to reaffirm our view that there will be some serious long-term benefits resulting from the acquisition and its payment network. Capital One is one of only two banks in the world with their own credit card network, the other being American Express. We will look for the company to leverage that edge into earnings growth and for the stock to be rewarded for it with a higher multiple as the integration progresses and management executes on their game plan. We were surprised by Thursday's more than 4% stock drop on Dover 's earnings. In addition to a top and bottom-line beat, the company reported a record adjusted segment EBITDA margin, an acceleration in bookings that provides visibility into the future. It also outlined several growth and productivity investments to support long-term growth. Compounding the strong results, management raised its full-year outlook on both revenue growth and adjusted earnings per share. For the week, Dover lost about 1%. Like Dover, Honeywell stock was also dinged after it reported Thursday morning, despite the results coming in largely better than expected. Shares were our worst performer of the week, down 5.2%. While there was some weakness in aerospace and in segment margin performance, we were satisfied with the explanation provided by management on the call and believe the weakness provides a buying opportunity ahead of what we think will be a value-creating breakup into three separate operating companies. The split will start in the fourth quarter of this year, when management spins off the advanced materials business, and continue in 2026 with the separation of aerospace, which will leave the automation business as the third public company. In the week ahead, we will get seven more Club name earnings, including Amazon , Apple , Meta Platforms , and Microsoft . (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Business Wire
an hour ago
- Business Wire
Allied Gaming & Entertainment Urges Stockholders to Take Caution Against Misleading and Factually Incorrect Statements Issued by Knighted Pastures Regarding ISS Report
NEW YORK--(BUSINESS WIRE)--Allied Gaming & Entertainment, Inc. (NASDAQ: AGAE) (the 'Company', 'AGAE' or 'Allied'), a global experiential entertainment company, announced today that a leading independent proxy advisory firm, Institutional Shareholder Services Inc. ('ISS'), has recommended withhold votes on five of the six director candidates that Knighted Pastures, LLC ('Knighted' or the 'dissident') has proposed at AGAE's upcoming combined 2024/2025 Annual Meeting on August 4, 2025. The Company also urges stockholders to take caution against relying on statements made by Knighted in its press release on the ISS recommendation. Of particular note, Knighted's claim that ISS recommended stockholders to vote for the election of Knighted's Class B director candidates to the Company's Board of Directors is factually incorrect. In fact, ISS recommended that stockholders vote for just one of Knighted's candidates, Roy Choi. Allied has previously offered Roy Choi a Board seat in an attempt to settle the proxy contest and related litigation but Mr. Choi has refused this offer. In addition, ISS recommended stockholders vote against Knighted's proposal to remove Mr. Yangyang Li, AGAE's Chairman of the Board, CEO and President, from the Company's Board of Directors. ISS also recommended stockholders support AGAE's candidate Roy Anderson. Additional findings from the ISS report that AGAE stockholders should consider include: (1) 'The dissident has presented a case for only limited change. ' '[S]upport for class B dissident nominee Choi is warranted. Shareholders should withhold votes from all other dissident nominees...' 'Over all periods of measurement through the unaffected date, AGAE's TSR outperformed the median of its peers …' 'TSR over the one-year period is positive …' '[T]he company's cash balances remain healthy …' The Allied Gaming Board of Directors has been and remains committed to acting in the best interests of all stockholders and unanimously recommends that stockholders vote "FOR" all six of AGAE's director nominees standing for election – Jingsheng (Jason) Lu, Guanzhou (Jerry) Qin, Mao Sun, Roy Anderson, Yushi Guo and Chi Zhao – on the WHITE proxy card today. PROTECT YOUR INVESTMENT IN ALLIED GAMING. REJECT ROY CHOI AND HIS NOMINEES BY VOTING THE WHITE PROXY CARD TODAY 'FOR' ALL SIX OF ALLIED GAMING'S NOMINEES, AND 'WITHHOLD' ON THE THREE KNIGHTED NOMINEES WE URGE YOU NOT TO SIGN OR RETURN ANY PROXY CARD OR VOTING INSTRUCTION FORM THAT MAY BE SENT TO YOU BY KNIGHTED. If you have any questions or need assistance in voting your WHITE proxy card, we encourage you to call our proxy advisers, MacKenzie Partners, Inc., Toll-Free at (800) 322-2885 or (212) 929-5500 or by email at AGAE@ Remember, you may be able to vote your shares by telephone, internet, and QR code voting may be available. Please refer to your proxy card/voting instruction form for details. If you have any questions or need assistance in voting your shares, please contact our proxy solicitor: MacKenzie Partners, Inc. 7 Penn Plaza, #503 New York, New York 10001 (212) 929-5500 (Call Collect) or Call Toll-Free (800) 322-2885 Email: AGAE@ Expand Advisors Paul Hastings LLP is serving as legal counsel, MacKenzie Partners, Inc. is serving as proxy solicitor and ADDO IR is serving as strategic communications advisor to AGAE. About Allied Gaming & Entertainment Allied Gaming & Entertainment Inc. (Nasdaq: AGAE) is a global experiential entertainment company focused on providing a growing world of gamers and concertgoers with unique experiences through renowned assets, products and services. For more information, visit Forward Looking Statements This press release contains certain forward-looking statements under federal securities laws. Forward-looking statements may include our statements regarding our goals, beliefs, strategies, objectives, plans, including product and service developments, future financial conditions, results or projections or current expectations. In some cases, you can identify forward-looking statements by terminology such as 'may,' 'will,' 'should,' 'expect,' 'plan,' 'anticipate,' 'believe,' 'estimate,' 'predict,' 'potential,' 'intend' or 'continue,' the negative of such terms, or other comparable terminology. Specific forward-looking statements include, but are not limited to, statements regarding our ability to execute on strategic and business plans and drive stockholder value, our projections on Allied Gaming's future financial performance and expense structure and our beliefs on the impact of Knighted director nominations and other actions of Knighted on the performance of the Company. These statements are subject to known and unknown risks, uncertainties, assumptions and other factors, many of which are outside our control, that may cause actual results to be materially different from those contemplated by the forward-looking statements. The inclusion of such information should not be regarded as a representation by us, or any person, that the objectives of Allied Gaming will be achieved. Important factors, among others, that may affect actual results or outcomes include: risks associated with our strategy, future direction or governance; the substantial uncertainties inherent in the acceptance of existing and future products and services; risks associated with our ability to retain key personnel; risks related to our common stock and the listing of our common stock on the Nasdaq Capital Market; risks associated with intellectual property; uncertainty around current and potential litigation and related legal expenses; and general economic, political and market conditions and events. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein and other risk factors discussed from time to time in our filings with the U.S. Securities and Exchange Commission (the 'SEC'), including those factors discussed under the caption 'Risk Factors' in our most recent annual report on Form 10-K, filed with the SEC on June 9, 2025, as well as subsequent reports filed with the SEC. Readers are also urged to carefully review and consider the various disclosures we made in such Annual Report on Form 10-K and in subsequent reports with the SEC. We assume no obligation and do not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today's date.
Business Wire
an hour ago
- Business Wire
Hawaii American Water Granted New Rates by Hawaii Public Utilities Commission
HONOLULU--(BUSINESS WIRE)--The Hawaii Public Utilities Commission (HPUC) has approved new wastewater rates for Hawaii American Water's Hawaii Kai, Mauna Lani, and Waimea service areas. The company's rate request was filed on August 5, 2024, and was primarily driven by over $40 million in local infrastructure upgrades in all three districts. The new rates reinforce the company's commitment to replace aging infrastructure, provide safe and reliable service, comply with environmental regulations and support infrastructure improvements for treatment plants, collection systems and pump stations. 'We are committed to making necessary infrastructure investments that allow us to continue providing safe and reliable wastewater services, while also enhancing the systems for long-term sustainability, resiliency and environmental protection,' said Lee Mansfield, Senior Manager Operations, Hawaii American Water. 'Our approach to consistent and efficient investment balanced with managing costs helps us deliver reliable and affordable service to our customers.' New rates are expected to be effective in early August 2025. The typical single-family customer in Hawaii Kai will see a monthly rate increase of approximately $4. For our Big Island operations at Mauna Lani and Waimea the typical single-family customer will see a rate increase of approximately $18 to $25 per month. The last rate adjustments were September 2003 for Mauna Lani operations and January 2011 for Waimea operations. The company last filed a rate case for the Hawaii Kai system in 2021. Customers will receive information about the new rates on their Hawaii American Water bill. Information will also be available on the company's website under Customer Service Billing, Your Wastewater Rates. About American Water American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to more than 14 million people with regulated operations in 14 states and on 18 military installations. American Water's 6,700 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders. For more information, visit and join American Water on LinkedIn, Facebook, X and Instagram. About Hawaii American Water Hawaii American Water, a subsidiary of American Water, provides high-quality wastewater services to approximately 30,000 people. AWK-IR
